Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Mar 9, 2005

30339_dirs_2005-03-09_350a2863-07b2-457a-8edf-545ce1bdb66c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-07

Reporting Person: HUGILL HERBERT L (Pres.of the Americas, Pharma.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-03-07 Common stocks A 3365 Acquired 22745.0438 Direct
2005-03-07 Common stocks A 1447.69 $25.5700 Acquired 6294.5333 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-03-07 Stock Option (Right to Buy) $25.5300 A 13000 Acquired 2015-03-09 Common Stock (13000.00) Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F2: Bonus and incentive shares granted on 3/7/05.